Pricing Log in Create free account
Friday 6 November 2026 Export ARQT’s income statement to Excel — free account

Arcutis Biotherapeutics, Inc.

ARQT Healthcare Biotechnology

Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024.

Revenue
+45.1%
EPS
+12.0%
Free cash flow
+1,171.9%
Total debt
+0.83%

Quarter to September 2026, against a year earlier

25.55 1.45 −5.37%
Market cap
$3.4B
P/E
112×
Fwd P/E
81.2×
Dividend yield
—
F-score
4/9
Altman Z
6.98
Beneish M
−1.52
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Arcutis Biotherapeutics, Inc. (ARQT) Current ratio

Alert me on Current ratio

Arcutis Biotherapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.9×, down 0.2× from fiscal 2025 (3.2×). Over the past ten years it has ranged from 3.2× (fiscal 2025) to 20.3× (fiscal 2019) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 4.9× and in line with the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.2× (23.59%)
FY2024 4.1× (41.45%)
FY2023 7.1× (38.80%)
FY2022 11.6× (4.27%)
FY2021 12.1× (6.72%)
FY2020 13.0× (36.28%)
FY2019 20.3× 6.35%
FY2018 19.1× 246.39%
FY2017 5.5× —

Quarterly newest first

Period Current ratio Change
Sep 2026 2.9× 0.20%
Jun 2026 2.9× 8.67%
Mar 2026 2.7× (15.26%)
Dec 2025 3.2× (9.51%)
25 more quarters

Against its own ten years

Low 3.2× High 20.3×
Ten-year median 11.6×
Current reading's percentile 11

Current ratio against peers

Company Current ratio
TNGX Tango Therapeutics, Inc. compare 50.8×
DNTH Dianthus Therapeutics, Inc. compare 30.0×
RLAY Relay Therapeutics, Inc. compare 18.3×
EWTX Edgewise Therapeutics, Inc. compare 16.2×
ABCL AbCellera Biologics Inc. compare 12.8×
DFTX Definium Therapeutics, Inc. compare 6.9×
IOVA Iovance Biotherapeutics, Inc. compare 5.2×
LEGN Legend Biotech Corporation Sponsored ADR compare 3.0×
ARQT Arcutis Biotherapeutics, Inc. 2.9×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on ARQT